Aveanna Healthcare (AVAH) Expected to Announce Earnings on Thursday

Aveanna Healthcare (NASDAQ:AVAH) is projected to release its Q3 2026 results before the market opens on Thursday, November 12th. Analysts expect Aveanna Healthcare to post earnings of $0.2072 per share and revenue of $679.48 million for the quarter. Interested persons can check the company’s upcoming Q3 2026 earnings report page for the latest details on the call scheduled for Thursday, November 12, 2026 at 10:00 AM ET.

Aveanna Healthcare (NASDAQ:AVAH) last released its quarterly earnings results on Thursday, August 13th. The company reported $0.22 EPS for the quarter, beating the consensus estimate of $0.17 by $0.05. Aveanna Healthcare had a net margin of 10.56% and a return on equity of 80.70%. The firm had revenue of $670.48 million for the quarter, compared to analyst estimates of $638.61 million. On average, analysts expect Aveanna Healthcare to post $0.77 EPS for the current fiscal year and $0.87 EPS for the next fiscal year.

Aveanna Healthcare Stock Down 0.1%

NASDAQ:AVAH opened at $13.19 on Wednesday. The company has a quick ratio of 1.16, a current ratio of 1.16 and a debt-to-equity ratio of 4.47. The stock has a market capitalization of $2.88 billion, a price-to-earnings ratio of 10.72, a price-to-earnings-growth ratio of 0.81 and a beta of 2.03. Aveanna Healthcare has a 52 week low of $5.93 and a 52 week high of $14.71. The stock’s fifty day moving average is $13.09 and its two-hundred day moving average is $9.40.

Insiders Place Their Bets

In related news, major shareholder Robert M. Williams, Jr. sold 14,500,002 shares of Aveanna Healthcare stock in a transaction on Thursday, August 20th. The shares were sold at an average price of $11.50, for a total transaction of $166,750,023.00. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, major shareholder J.H. Whitney Equity Partners V sold 12,496,077 shares of the business’s stock in a transaction on Thursday, August 20th. The shares were sold at an average price of $11.50, for a total transaction of $143,704,885.50. The SEC filing for this sale provides additional information. In the last 90 days, insiders have sold 48,566,081 shares of company stock worth $558,509,932. 5.30% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on the stock. UBS Group upped their target price on shares of Aveanna Healthcare from $8.00 to $13.00 and gave the stock a “neutral” rating in a research note on Friday, August 14th. Weiss Ratings upgraded shares of Aveanna Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a report on Wednesday, October 14th. Royal Bank Of Canada lifted their price objective on shares of Aveanna Healthcare from $10.00 to $16.00 and gave the stock an “outperform” rating in a research report on Monday, August 24th. Wall Street Zen lowered Aveanna Healthcare from a “strong-buy” rating to a “buy” rating in a report on Saturday, August 15th. Finally, JPMorgan Chase & Co. increased their target price on Aveanna Healthcare from $8.00 to $15.00 and gave the company a “neutral” rating in a report on Monday, September 14th. One investment analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $14.25.

About Aveanna Healthcare

Aveanna Healthcare Holdings Inc. is a U.S. provider of home-based healthcare services for children and adults with complex medical needs. Its services include private-duty nursing and personal care, home health nursing and therapy, and hospice care, helping patients receive support in their homes and communities. The company also provides medical supplies and related services, including products used for enteral nutrition. Aveanna serves patients and families across multiple states through a network of clinicians, caregivers, and local operations.